Skip to main content
Kamada Ltd. logo

Kamada Ltd. — Investor Relations & Filings

Ticker · KMDA ISIN · IL0010941198 TA Manufacturing
Open in API
Filings indexed 822 across all filing types
Latest filing 2017-02-10 Capital/Financing Update
Country IL Israel
Listing TA KMDA

About Kamada Ltd.

https://www.kamada.com

Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.

Recent filings

Filing Released Lang Actions
Other Report or Announcement
Capital/Financing Update Classification · 1% confidence The document explicitly states it is a "FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933". Form S-8 is used by companies to register securities (like shares) that are offered under employee benefit plans, such as stock option or share award plans. The document details the calculation of registration fees for Ordinary Shares to be issued under the "Kamada Ltd. 2011 Israeli Share Award Plan". This filing type is not explicitly listed in the provided definitions (AGM-R, 10-K, AR, etc.). Since it is a specific SEC registration form related to capital/securities issuance for employee plans, it most closely aligns with 'Capital/Financing Update' (CAP) or, given its nature as a specific SEC filing not covered by the primary definitions, it should fall under the general regulatory/miscellaneous category. However, Form S-8 is fundamentally about registering securities for issuance, which is a form of capital activity. Given the options, and recognizing that specific SEC registration forms often fall outside the main operational reports, I must check if any category fits. 'CAP' (Capital/Financing Update) is the closest fit as it deals with the registration of shares for issuance under a plan. If CAP is too broad, 'RNS' (Regulatory Filings) is the fallback. Since this is a registration statement for shares being offered, it is a direct capital action. I will classify it as CAP, as it registers the capital being made available through the plan, but acknowledge that specific SEC forms often default to RNS if CAP is reserved for announcements of completed financing rounds. Given the context of registering shares for an employee plan, it is a specific type of capital action. Let's re-evaluate the definitions. None of the definitions perfectly match 'Form S-8 Registration Statement'. 'CAP' covers fundraising/financing activities. Registering shares for an employee plan is a financing/capital activity. I will use CAP as the most relevant functional category, but if the system strictly requires a match, RNS is the fallback for non-listed SEC forms. Since the document is a full registration statement, not just an announcement of a report, it is not RPA or RNS by the 'MENU VS MEAL' rule unless it was an announcement *about* filing the S-8. Since this *is* the S-8, CAP is the best fit for registering securities for issuance. If CAP is deemed too narrow, RNS is the final catch-all. I will proceed with CAP as it directly relates to the registration of securities for issuance.
2017-02-10 English
Other Report or Announcement
Report Publication Announcement Classification · 1% confidence The document is a regulatory filing notification from KAMADA LTD, referencing the Israel Securities Authority and the Tel Aviv Stock Exchange. It explicitly states, 'Attached hereto is a report on *S-8* *S-8_isa.pdf*'. The S-8 form in the US context typically relates to registration statements for employee stock option plans, which falls under capital/financing activities or general regulatory reporting. Given the document's short length (1706 chars) and its primary function being to announce the attachment of a specific report ('S-8_isa.pdf') rather than containing the full content of that report, it aligns best with the 'Report Publication Announcement' (RPA) definition, as it announces the publication of another document. If the content of the S-8 itself were present, it might be classified as CAP, but here it is just the announcement wrapper.
2017-02-10 English
Other Report or Announcement
Board/Management Information Classification · 1% confidence The document is a press release titled "Kamada Announces Appointment of Biopharmaceutical Industry Veteran, Gwen Melincoff, to its Board of Directors." The content details the addition of a new director to the Board, including her background, experience, and quotes from the Chairman regarding the appointment. This directly corresponds to the definition of Board/Management Information.
2017-02-08 English
Other Report or Announcement
Board/Management Information Classification · 1% confidence The document is a regulatory filing notification from KAMADA LTD, reported via MAGNA to the Israel Securities Authority and the Tel Aviv Stock Exchange on 08/02/2017. The key content states: "Attached hereto is a report on *Kamada Announces Appointment of Biopharmaceutical Industry Veteran, Gwen Melincoff, to its Board of Directors*" followed by a reference to an attached PDF. This indicates the document itself is an announcement about a change in the Board of Directors, rather than the full report or a general regulatory filing. According to the definitions, 'Board/Management Information' (MANG) covers the announcement of changes in the company's board of directors or senior management. The short length and the nature of announcing an attached report strongly suggest this is the announcement itself, fitting the MANG category.
2017-02-08 English
Immediate Report
Earnings Release Classification · 1% confidence The document is titled "Kamada Reports Financial Results for the Fourth Quarter and Full-Year 2016" and contains detailed financial highlights for both the three months ended December 31, 2016, and the twelve months ended December 31, 2016. It includes key metrics like total revenues, gross profit, net loss, and guidance for the next year (2017). This structure is characteristic of an Earnings Release (ER), which provides the initial announcement of periodical financial results, often accompanied by a conference call announcement. While it contains detailed financial data, it is presented as a press release announcing the results, not the comprehensive, audited filing (like a 10-K) or a standalone interim report (IR) which typically has a more formal structure. The presence of a conference call announcement strongly supports the ER classification. Q4 2016
2017-02-06 English
Immediate Report
Report Publication Announcement Classification · 1% confidence The document is an 'Immediate Report' filed with the Israel Securities Authority and the Tel Aviv Stock Exchange. It explicitly states: 'Attached hereto is a report on *Kamada Reports 2016 Fourth Quarter and Full Year Financial Results*'. This structure—a brief regulatory filing announcing the availability of a detailed financial report (Fourth Quarter and Full Year Results)—fits the definition of a Report Publication Announcement (RPA). It is not the full financial report itself (which would likely be 10-K or IR), nor is it a transcript (CT) or a management discussion (MDA). Given the short length and the explicit mention of attaching/publishing the results report, RPA is the most appropriate classification.
2017-02-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.